Lunch & Learn, October 5th, La Jolla Institute for Immunology: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

genOway presentation

Event
-
September 23, 2026

Join us for a Lunch & Learn session focused on one of the most critical challenges in modern drug development: improving the predictive power and translatability of in vivo models.

📅 Monday, October 5th, 2026

🕛 12:00 - 1:00 PM

📍 La Jolla Institute for Immunology, San Diego, USA

In this session, we will focus on:

  • Next-generation humanized mouse models engineered to more accurately recapitulate human physiology
  • How these models help improving translational relevance and predictive power in preclinical research

This informal lunchtime session will include:

  • Expert presentations
  • Interactive discussion and Q&A
  • Networking over lunch

Spaces are limited, secure your place today by filling the form below.

Lunch & Learn, October 5th, La Jolla Institute for Immunology: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

Get in touch

Let us know how we can help

Other news & events

Lunch & Learn, October 5th, La Jolla Institute for Immunology: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Sep 2026
Read on
BioJapan, Yokohama, October 7-9, 2026
Conference
genOway presentation
Event
-
Sep 2026
Read on
Festival of Biologics, Basel Switzerland, October 13-15, 2026
Conference
genOway presentation
Event
-
Sep 2026
Read on
PBSS workshop: Preclinical Development and IND Filing for Antibody-Based Therapeutics: Nuts, Bolts, and Best Practices, San Diego, October 1st, 2026
Conference
Event
-
Sep 2026
Read on
The 85th Annual Meeting of the Japanese Cancer Association, Kioto, September 24-26, 2026
Conference
Event
-
Sep 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe